Eutylone

Eutylone is a psychoactive drug and research chemical that belongs to the cathinone family. It is also known by its systematic name, β-Keto-ethylbenzodioxolylbutanamine (βk-EBDB). Eutylone is a stimulant that has been associated with effects such as euphoria, increased energy, and enhanced focus. However, it is also associated with potential risks and side effects.

History

Eutylone was first synthesized in the 1960s as part of a group of compounds known as phenethylamines. However, it did not gain significant attention until the 21st century, when it began to appear in products sold as legal highs or designer drugs.

Pharmacology

Eutylone acts as a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI), increasing the levels of these neurotransmitters in the brain. This results in the stimulant and euphoric effects associated with the drug. However, the exact mechanisms of action are not fully understood, and further research is needed.

Legal Status

The legal status of Eutylone varies by country. In the United States, it is classified as a Schedule I drug under the Controlled Substances Act. In the United Kingdom, it is a Class B drug under the Misuse of Drugs Act. Other countries have similar laws regulating or banning the possession, sale, and use of Eutylone.

Risks and Side Effects

Use of Eutylone can lead to a range of side effects, including insomnia, anxiety, paranoia, and psychosis. It can also cause physical effects such as increased heart rate, high blood pressure, and in severe cases, organ damage or death. Long-term use can lead to substance dependence and withdrawal symptoms.

See Also

• Cathinone
• Psychoactive drug
• Research chemical
• Stimulant

This article is a stub related to pharmacology. You can help WikiMD by expanding it!